Hepatitis C virus (HCV) diminishes health related quality of life (HRQOL), and it is now
common to measure HRQOL in clinical trials. We sought to summarize the HRQOL data in …

Hepatitis C virus (HCV) is the etiological agent accounting for chronic liver disease in
approximately 2–3% of the population worldwide. HCV infection often leads to liver fibrosis …

Metabolic processes utilize a variety of differing and contrasting biochemical routes to
enable synthesis of degradation and activation or deactivation of substances; in addition …

Hepatitis C virus (HCV) is a highly pathogenic human virus associated with liver fibrosis,
steatosis, and cancer. In infected cells HCV induces oxidative stress. Here, we show that …

OBJECTIVE—The purpose of this study was to explore the initial pathogenic mechanisms of
diabetes associated with hepatitis C virus (HCV) infection. RESEARCH DESIGN AND …

By definition, hepatogenous diabetes is directly caused by loss of liver function, implying that
it develops after cirrhosis onset. Therefore, it should be distinguished from type 2 diabetes …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, affecting 3% of
the world's population (1, 2). The disease is characterized by silent onset in most infected …

AIM: To determine the risk factors for new-onset diabetes mellitus (NODM) after liver
transplantation by conducting a systematic review and meta-analysis. METHODS: We …

Living kidney donation is increasing because of prolonged waiting times on the transplant
list, as well as improved outcomes for recipients. In 2001, the number of living donors …

Abstract Background and Aims: Interferon (IFN) plus ribavirin therapy for chronic hepatitis C
(CHC) virus infection has been associated with thyroid dysfunction. The goal of our current …